QTc interval in a sample of long-term schizophrenia inpatients.
This naturalistic study attempted to determine the prevalence of prolonged QTc interval in a relatively large population of inpatients hospitalized with chronic schizophrenia, and to explore QTc relationship with demographic variables, metabolic parameters and prescribed treatments. All inpatients from a Spanish long-term psychiatric hospital were cross-sectionally investigated to determine the prevalence of QTc prolongation and metabolic syndrome. The sample with a DSM-IV diagnosis of schizophrenia included 171 Caucasian inpatients, all of Spanish origin. A prolonged QTc interval was defined as >450 ms in men and >470 ms in women. The relationships between QTc and other continuous variables were assessed using a linear regression model with QTc as the dependent variable. Only 10 patients (6%) had a prolonged QTc interval; one case was possibly explained by hypokalemia. Three patients (2%) had a QTc > 500 ms. Gender, old age (> or = 50 years old), current smoking, systolic blood pressure, HDL cholesterol and history of arrhythmia were found to have significant effects on QTc interval in a linear regression analysis. After controlling for significant variables, the mean QTc interval was not significantly influenced by antipsychotic dose, type of antipsychotic treatment, the use of depot antipsychotics, or the number of different antipsychotics prescribed. Our study focused on long-term schizophrenia inpatients with frequent antipsychotic polypharmacy and high antipsychotic doses, and suggested that after excluding the case with hypokalemia length of QTc was associated with history of arrhythmias and with metabolic factors, while the effects of antipsychotic compound or class were not so evident.
Ramos-Ríos
Ramón
R
Department of Psychiatry, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain.
Arrojo-Romero
Manuel
M
Paz-Silva
Eduardo
E
Carballal-Calvo
Fernando
F
Bouzón-Barreiro
José L
JL
Seoane-Prado
Jorge
J
Codesido-Barcala
Rosario
R
Crespí-Armenteros
Alicia
A
Fernández-Pérez
Ramón
R
López-Moríñigo
Javier D
JD
Tortajada-Bonaselt
Ignacio
I
Diaz
Francisco J
FJ
de Leon
Jose
J
D000328:Adult; D000367:Age Factors; D000368:Aged; D000704:Analysis of Variance; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D015992:Body Mass Index; D004562:Electrocardiography / Q000379:methods; D005260:Female; D006339:Heart Rate / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D007297:Inpatients; D008133:Long QT Syndrome / Q000139:chemically induced* / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D011188:Potassium / Q000378:metabolism; D015995:Prevalence; D012044:Regression Analysis; D012559:Schizophrenia / Q000188:drug therapy / Q000503:physiopathology*; D012737:Sex Factors
D014150:Antipsychotic Agents; D011188:Potassium